Hyperbaric oxygen therapy increases bone infection cure rates to 86%

Hyperbaric oxygen therapy increases bone infection cure rates to 86%

Understanding osteomyelitis and why bone infections resist standard treatment
Osteomyelitis is an infection of the bone or bone marrow that becomes chronic and refractory when it persists beyond 4 to 6 weeks despite appropriate antibiotic therapy and surgical debridement. The infection creates an environment of reduced blood flow and oxygen deprivation within the bone, which impairs the immune system’s ability to fight the infection and prevents antibiotics from reaching effective concentrations.
With surgery and antibiotics alone, the cure rate for chronic refractory osteomyelitis is approximately 50%. When HBOT is added as an adjunct therapy, cure rates rise to 85–86%. Bay Area Hyperbarics has treated bone infections for over 25 years, including infections in the face, orbit, ear, skull, vertebrae, chest, ribs, pelvis, arms, hands, fingers, legs, feet and toes. Our founder Lisa St. John used HBOT to heal her own seven-year facial bone infection, which inspired her to open the clinic.
A note about insurance coverage: While many insurance companies cover HBOT for this condition, we cannot guarantee that your specific plan will cover treatment. Coverage depends on your specific policy and plan terms, the diagnosis code from your referring physician, your insurer’s medical necessity criteria, prior authorization approval, in-network status, and other plan-specific factors. Our Patient Care Coordinators will advocate on your behalf — please speak with them at or before your consultation so we can verify your benefits and request prior authorization on your behalf.
Persistent bone pain, swelling and tenderness
Infection that resists antibiotics and surgical debridement
Fatigue, cognitive impairment and reduced daily function
Risk of bone loss, deformity and surgical complications
How pressurized oxygen eliminates bone infections and rebuilds bone
HBOT attacks bone infections from multiple angles — killing bacteria, enhancing antibiotics and stimulating the bone's own healing capacity.
Kills bacteria and makes antibiotics more effective
Supercharges bone and tissues with oxygen
Regrows new blood vessels and improves blood flow
Stimulates stem cell mobilization for bone repair
Grows new tissue, skin and collagen
Often completely heals bone infections
For Providers
Clinical evidence for HBOT in osteomyelitis and bone infections
HBOT for chronic refractory osteomyelitis is an FDA, AMA and Medicare-approved indication with controlled trial evidence demonstrating cure rate improvement from approximately 50% to 85–86% when added to surgery and antibiotics.
Davis et al. — controlled study (1986): The landmark controlled study of HBOT in chronic refractory osteomyelitis, published in the Journal of Bone and Joint Surgery, evaluated patients with refractory bone infections who had failed standard antibiotic and surgical management. Adding HBOT to the treatment regimen increased the cure rate from approximately 50% to 85–86%, a statistically significant and clinically dramatic improvement. The study established HBOT as the most effective adjunct available for refractory osteomyelitis and contributed directly to its FDA and Medicare approval. [Davis JC et al. J Bone Joint Surg Am. 1986;68(8):1210–1217. PMID: 3771601]
Mader et al. — antibiotic potentiation mechanism (1980): Research by Mader and colleagues demonstrated that aminoglycoside antibiotics — a mainstay of osteomyelitis treatment — require oxygen to transport across bacterial cell membranes and achieve bactericidal activity. In the hypoxic environment of infected bone, aminoglycosides are largely ineffective even at full systemic doses. HBOT restores bone tissue oxygen to levels that enable full aminoglycoside bactericidal activity, providing a direct pharmacological synergy between HBOT and antibiotic therapy. [Mader JT et al. J Infect Dis. 1980;142(6):915–921. PMID: 7462694]
Bone tissue oxygen restoration: Chronically infected bone becomes progressively hypoxic as the inflammatory cell infiltrate increases metabolic demand and as infection destroys the microvascular supply. Neutrophil oxidative killing — the primary defense against bacterial infection — requires molecular oxygen to generate the reactive oxygen species used to destroy bacteria. In hypoxic infected bone, this mechanism is completely disabled. HBOT restores bone tissue oxygen to levels that fully reconstitute neutrophil oxidative killing, re-enabling the immune mechanism that infection has suppressed. [Hopf HW et al. Arch Surg. 1997;132(9):997–1004. PMID: 9301620]
Osteoblast activation and bone healing: Beyond infection control, HBOT stimulates osteoblast differentiation and activity in infected bone, promoting the bone remodeling and regeneration needed to heal the osseous defects created by osteomyelitis. HBOT also drives angiogenesis in infected bone tissue, restoring the vascular supply that delivers oxygen, nutrients and immune cells for sustained healing after the acute infection is controlled.
Bay Area Hyperbarics clinical experience: Our clinic has treated bone infections across virtually every anatomical site for over 25 years. Our founders’ personal healing from a seven-year facial bone infection with HBOT inspired the clinic’s founding. HBOT is coordinated alongside infectious disease and surgical management, and numerous private insurers cover it alongside Medicare.
Your path from chronic bone infection to complete healing
We design a personalized HBOT protocol coordinated with your surgeon and infectious disease specialist.
Comprehensive infection and bone health assessment
Our medical team reviews your infection history, imaging, antibiotic regimen and surgical plan to design an HBOT protocol that complements your existing treatment.

Daily HBOT sessions in our pressurized chambers
You breathe 100% oxygen in a pressurized chamber for approximately 90 minutes per session. Osteomyelitis protocols typically involve 40 to 60 sessions.

Progressive infection resolution and bone regeneration
We track healing progress throughout treatment. Most patients experience progressive reduction in pain, swelling and infection markers as bone tissue regenerates.

Frequently Asked Questions
Answers to the questions patients ask most about hyperbaric oxygen therapy for osteomyelitis and bone infections.
Bone infections create a low-oxygen environment where the immune system and antibiotics cannot function effectively. HBOT floods infected bone with 1,200% more oxygen, reactivating immune killing mechanisms, enhancing antibiotic penetration and stimulating new blood vessel and bone growth. This raises the cure rate from 50% to 85-86%.
Start healing your bone infection today
Schedule a free consultation to discuss how hyperbaric oxygen therapy can heal your osteomyelitis and help you return to an active, pain-free life.

